| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.27 | 0.4 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.13 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.3 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |